BioSpace News Archive

Telo Genomics Announces Private Placement of Units

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) is pleased to announce a non-brokered private placement of units (“Units”) at a price of $0.25 per Unit for gross proceeds of $2,000,000 (the “Offering”).

May 19, 2023
·
4 min read
Biotech Bay

Data from Mirum’s LIVMARLI Studies Presented at ESPGHAN Annual Meeting

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced data presented during the 55th European Society for Pediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting.

May 19, 2023
·
10 min read
Policy

CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech

Motion to transfer U.S. litigation to Eastern District of Virginia granted at CureVac’s request and expected to significantly accelerate U.S. litigation timeline.

May 19, 2023
·
6 min read
Biotech Bay

Alterity Therapeutics CEO David Stamler to Present at the SHARE Series Monday Management Update on Monday, May 22, 2023

Alterity Therapeutics today announced that David Stamler, M.D., Chief Executive Officer of Alterity will present at the SHARE Series Monday Management Update on Monday, May 22, 2023, at 11:00 am ET or 1:00am AEST Tuesday, May 23, 2023.

May 19, 2023
·
1 min read
Lone Star Bio

Taysha Gene Therapies Presents Preclinical Data on TSHA-102 for Rett Syndrome Demonstrating Cellular Regulation of MeCP2 Expression in Key Mouse Models at the American Society of Gene and Cell Therapy 26th Annual Meeting

Taysha Gene Therapies today presents preclinical data from neonatal mouse models on TSHA-102 for Rett syndrome, including new data in wild-type mice, at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting.

May 19, 2023
·
7 min read
Genetown

Enveric Biosciences to Participate in 2023 BIO International Convention in Boston

Enveric Biosciences, Inc. today announced its participation in this year’s 2023 BIO International Convention, which is being held in Boston, MA, June 5-8, 2023.

May 19, 2023
·
4 min read
Pharm Country

WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens

WBB Research Institute (WBBRI) hosted a Demi-Colton Virtual Salon on the need for a global response to Candida auris and other deadly pathogens.

May 19, 2023
·
2 min read
BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share

BriaCell Therapeutics Corp. is pleased to announce that the Company has completed the previously-announced strategic investment by Prevail Partners, LLC in the Company, in accordance with a stock purchase agreement entered into between the Company and Prevail Partners on May 12, 2023.

May 19, 2023
·
4 min read